Background Myosteatosis has been reported to be a novel biomarker that could predict
survival outcomes in patients with colorectal cancer. However, results have been conflicting …

Background Myosteatosis and sarcopenia are forms of muscle depletion that impair the
normal physiological function of elderly patients, resulting in a worse prognosis. This study …

Background The evidence that body composition parameters influence multiple cancer
outcomes is rapidly expanding. Excess adiposity deposits in muscle tissue, termed …

BACKGROUND: Muscle loss, characterized by reduced muscle mass (myopenia), and
infiltration by intermuscular and intramuscular fat (myosteatosis), predicts a poor short-term …

Background Increasing evidence has suggested that sarcopenia is linked with cancer
prognosis, but only limited data have focused on the impact of myosteatosis on cancer …

Background The aim of this study was to evaluate whether sarcopenia or myosteatosis have
an impact on short-and long-term results in patients who were surgically treated for …

Objective: We examined the relationships between computed tomography (CT)–defined
skeletal muscle parameters and the systemic inflammatory response (SIR) in patients with …

Background & aims Patients with pancreatic cancer have a poor prognosis, are often
cachectic, and frequently demonstrate features of systemic inflammation, which may …

Background Sarcopenia is defined as the loss of skeletal muscle mass, accompanied by
decreased muscle strength, and consists of myopenia and myosteatosis. Recent evidence …

Background Muscle depletion is characterized by reduced muscle mass (myopenia), and
increased infiltration by intermuscular and intramuscular fat (myosteatosis). This study …